<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02637726</url>
  </required_header>
  <id_info>
    <org_study_id>AIVCM</org_study_id>
    <nct_id>NCT02637726</nct_id>
  </id_info>
  <brief_title>Bispectral Index Under Propofol Anesthesia in Children : a Study Between TIVA and TCI</brief_title>
  <official_title>Bispectral Index Under Propofol Anesthesia in Children : a Comparative Randomised Study Between TIVA and TCI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pr Isabelle CONSTANT</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Armand Trousseau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In children, only a few studies have compared different modes of propofol infusion during a
      total intravenous anesthesia (TIVA) with propofol and remifentanil. The aim of this study is
      to compare Bispectral Index (BIS) profiles (percentage of time spent at adequate BIS values)
      between four modes of propofol infusion: titration of the infusion rate on clinical signs
      (TIVA0), titration of the infusion rate on the BIS (TIVABIS), target controlled infusion
      (TCI) guided by the BIS either with the Kataria model (TCI KBIS) or the Schnider model (TCI
      SBIS).

      Methods: Children will be prospectively randomized into the 4 groups. In the TIVA0 group the
      anesthesiologist is blinded to the BIS. In each group, the percentage of time with adequate
      BIS values (45-55), the bias and imprecision will be calculated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of time spent at adequate BIS values</measure>
    <time_frame>from the beginning to the end of the anesthesia</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>TIVA0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol : TIVA guided by clinical signs. Remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TIVA BIS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>propofol : TIVA guided by EEG Monitoring. Remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCI KBIS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol : TCI Kataria guided by EEG Monitoring. Remifentanil.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TCI SBIS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol : TCI Schnider guided by EEG Monitoring. Remifentanil.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol : TCI Schnider</intervention_name>
    <description>Target controlled infusion using schnider model for propofol</description>
    <arm_group_label>TCI SBIS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol : TCI Kataria</intervention_name>
    <description>Target controlled infusion using Kataria model for propofol</description>
    <arm_group_label>TCI KBIS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol : TIVA</intervention_name>
    <description>Total intravenous anesthesia without use of a pharmokinetic model</description>
    <arm_group_label>TIVA0</arm_group_label>
    <arm_group_label>TIVA BIS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG Monitoring</intervention_name>
    <description>Maintaining a bispectral index between 45 and 55</description>
    <arm_group_label>TIVA BIS</arm_group_label>
    <arm_group_label>TCI KBIS</arm_group_label>
    <arm_group_label>TCI SBIS</arm_group_label>
    <other_name>BISPECTRAL INDEX</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>Remifentanil at discretion of the anesthesiologist</description>
    <arm_group_label>TIVA0</arm_group_label>
    <arm_group_label>TIVA BIS</arm_group_label>
    <arm_group_label>TCI KBIS</arm_group_label>
    <arm_group_label>TCI SBIS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  weighting more than 15 kg;

          -  American Society of Anesthesiologists physical status I or II

          -  scheduled for middle ear surgery

        Exclusion Criteria:

          -  cardiovascular, neurological, hepatic or renal impairment, if their body mass index
             was above 95th percentile or if they received any drug interfering with the central
             nervous system.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle Constant, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpital Armand Trousseau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departement d'anesthesie Hopital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2015</study_first_submitted>
  <study_first_submitted_qc>December 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2015</study_first_posted>
  <last_update_submitted>December 21, 2015</last_update_submitted>
  <last_update_submitted_qc>December 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital Armand Trousseau</investigator_affiliation>
    <investigator_full_name>Pr Isabelle CONSTANT</investigator_full_name>
    <investigator_title>Professor Isabelle Constant</investigator_title>
  </responsible_party>
  <keyword>Total intravenous anesthesia</keyword>
  <keyword>Target Controlled Infusion</keyword>
  <keyword>Propofol</keyword>
  <keyword>Bispectral index</keyword>
  <keyword>Children</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

